Literature DB >> 30503773

Type III-A CRISPR-Cas Csm Complexes: Assembly, Periodic RNA Cleavage, DNase Activity Regulation, and Autoimmunity.

Ning Jia1, Charlie Y Mo2, Chongyuan Wang3, Edward T Eng4, Luciano A Marraffini2, Dinshaw J Patel5.   

Abstract

Type ΙΙΙ CRISPR-Cas systems provide robust immunity against foreign RNA and DNA by sequence-specific RNase and target RNA-activated sequence-nonspecific DNase and RNase activities. We report on cryo-EM structures of Thermococcus onnurineus CsmcrRNA binary, CsmcrRNA-target RNA and CsmcrRNA-target RNAanti-tag ternary complexes in the 3.1 Å range. The topological features of the crRNA 5'-repeat tag explains the 5'-ruler mechanism for defining target cleavage sites, with accessibility of positions -2 to -5 within the 5'-repeat serving as sensors for avoidance of autoimmunity. The Csm3 thumb elements introduce periodic kinks in the crRNA-target RNA duplex, facilitating cleavage of the target RNA with 6-nt periodicity. Key Glu residues within a Csm1 loop segment of CsmcrRNA adopt a proposed autoinhibitory conformation suggestive of DNase activity regulation. These structural findings, complemented by mutational studies of key intermolecular contacts, provide insights into CsmcrRNA complex assembly, mechanisms underlying RNA targeting and site-specific periodic cleavage, regulation of DNase cleavage activity, and autoimmunity suppression. Published by Elsevier Inc.

Entities:  

Keywords:  5′ repeat tag pairing controls autoimmunity; DNase activity regulation by Glu residues; RNA cleavage with 6-nt periodicity; T. onnurineus Csm; cryo-EM; ternary complex assembly with crRNA and target RNA; type III-A CRISPR-Cas complexes

Mesh:

Substances:

Year:  2018        PMID: 30503773      PMCID: PMC6355164          DOI: 10.1016/j.molcel.2018.11.007

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  50 in total

1.  Cas3 is a single-stranded DNA nuclease and ATP-dependent helicase in the CRISPR/Cas immune system.

Authors:  Tomas Sinkunas; Giedrius Gasiunas; Christophe Fremaux; Rodolphe Barrangou; Philippe Horvath; Virginijus Siksnys
Journal:  EMBO J       Date:  2011-02-22       Impact factor: 11.598

2.  Crystal structure of the CRISPR-Cas RNA silencing Cmr complex bound to a target analog.

Authors:  Takuo Osawa; Hideko Inanaga; Chikara Sato; Tomoyuki Numata
Journal:  Mol Cell       Date:  2015-04-23       Impact factor: 17.970

3.  Structure Basis for Directional R-loop Formation and Substrate Handover Mechanisms in Type I CRISPR-Cas System.

Authors:  Yibei Xiao; Min Luo; Robert P Hayes; Jonathan Kim; Sherwin Ng; Fang Ding; Maofu Liao; Ailong Ke
Journal:  Cell       Date:  2017-06-29       Impact factor: 41.582

4.  Processing of X-ray diffraction data collected in oscillation mode.

Authors:  Z Otwinowski; W Minor
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

5.  Structure Reveals Mechanisms of Viral Suppressors that Intercept a CRISPR RNA-Guided Surveillance Complex.

Authors:  Saikat Chowdhury; Joshua Carter; MaryClare F Rollins; Sarah M Golden; Ryan N Jackson; Connor Hoffmann; Lyn'Al Nosaka; Joseph Bondy-Denomy; Karen L Maxwell; Alan R Davidson; Elizabeth R Fischer; Gabriel C Lander; Blake Wiedenheft
Journal:  Cell       Date:  2017-03-23       Impact factor: 41.582

Review 6.  Type III CRISPR-Cas systems: when DNA cleavage just isn't enough.

Authors:  Nora C Pyenson; Luciano A Marraffini
Journal:  Curr Opin Microbiol       Date:  2017-08-31       Impact factor: 7.934

Review 7.  Diversity, classification and evolution of CRISPR-Cas systems.

Authors:  Eugene V Koonin; Kira S Makarova; Feng Zhang
Journal:  Curr Opin Microbiol       Date:  2017-06-09       Impact factor: 7.934

8.  Short motif sequences determine the targets of the prokaryotic CRISPR defence system.

Authors:  F J M Mojica; C Díez-Villaseñor; J García-Martínez; C Almendros
Journal:  Microbiology       Date:  2009-03       Impact factor: 2.777

9.  CTFFIND4: Fast and accurate defocus estimation from electron micrographs.

Authors:  Alexis Rohou; Nikolaus Grigorieff
Journal:  J Struct Biol       Date:  2015-08-13       Impact factor: 2.867

10.  RNA-activated DNA cleavage by the Type III-B CRISPR-Cas effector complex.

Authors:  Michael A Estrella; Fang-Ting Kuo; Scott Bailey
Journal:  Genes Dev       Date:  2016-02-04       Impact factor: 11.361

View more
  34 in total

1.  Characterization of a novel type III CRISPR-Cas effector provides new insights into the allosteric activation and suppression of the Cas10 DNase.

Authors:  Jinzhong Lin; Mingxia Feng; Heping Zhang; Qunxin She
Journal:  Cell Discov       Date:  2020-05-12       Impact factor: 10.849

2.  Second Messenger cA4 Formation within the Composite Csm1 Palm Pocket of Type III-A CRISPR-Cas Csm Complex and Its Release Path.

Authors:  Ning Jia; Roger Jones; George Sukenick; Dinshaw J Patel
Journal:  Mol Cell       Date:  2019-07-17       Impact factor: 17.970

3.  CRISPR-Cas III-A Csm6 CARF Domain Is a Ring Nuclease Triggering Stepwise cA4 Cleavage with ApA>p Formation Terminating RNase Activity.

Authors:  Ning Jia; Roger Jones; Guangli Yang; Ouathek Ouerfelli; Dinshaw J Patel
Journal:  Mol Cell       Date:  2019-07-17       Impact factor: 17.970

4.  Structural basis for self-cleavage prevention by tag:anti-tag pairing complementarity in type VI Cas13 CRISPR systems.

Authors:  Beibei Wang; Tianlong Zhang; Jun Yin; You Yu; Wenhao Xu; Jianping Ding; Dinshaw J Patel; Hui Yang
Journal:  Mol Cell       Date:  2021-01-19       Impact factor: 17.970

Review 5.  Structure-based functional mechanisms and biotechnology applications of anti-CRISPR proteins.

Authors:  Ning Jia; Dinshaw J Patel
Journal:  Nat Rev Mol Cell Biol       Date:  2021-06-04       Impact factor: 94.444

6.  Target sequence requirements of a type III-B CRISPR-Cas immune system.

Authors:  Kaitlin Johnson; Brian A Learn; Michael A Estrella; Scott Bailey
Journal:  J Biol Chem       Date:  2019-05-19       Impact factor: 5.157

7.  Cmr3 regulates the suppression on cyclic oligoadenylate synthesis by tag complementarity in a Type III-B CRISPR-Cas system.

Authors:  Tong Guo; Fan Zheng; Zhifeng Zeng; Yang Yang; Qi Li; Qunxin She; Wenyuan Han
Journal:  RNA Biol       Date:  2019-07-17       Impact factor: 4.652

Review 8.  Chemistry of Class 1 CRISPR-Cas effectors: Binding, editing, and regulation.

Authors:  Tina Y Liu; Jennifer A Doudna
Journal:  J Biol Chem       Date:  2020-08-14       Impact factor: 5.157

9.  CRISPR-Cas13 Inhibitors Block RNA Editing in Bacteria and Mammalian Cells.

Authors:  Ping Lin; Shugang Qin; Qinqin Pu; Zhihan Wang; Qun Wu; Pan Gao; Jacob Schettler; Kai Guo; Rongpeng Li; Guoping Li; Canhua Huang; Yuquan Wei; George Fu Gao; Jianxin Jiang; Min Wu
Journal:  Mol Cell       Date:  2020-04-28       Impact factor: 17.970

10.  A jumbo phage that forms a nucleus-like structure evades CRISPR-Cas DNA targeting but is vulnerable to type III RNA-based immunity.

Authors:  Lucia M Malone; Suzanne L Warring; Simon A Jackson; Carolin Warnecke; Paul P Gardner; Laura F Gumy; Peter C Fineran
Journal:  Nat Microbiol       Date:  2019-12-09       Impact factor: 17.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.